Physician

Rama Poola, MD

According to 2025 Medicare claims, Rama Poola, MD (NPI: 1932362241) practices endocrinology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is HSHS MEDICAL GROUP INC (NPI: 1962644807; TIN: 263956318) and primary practice location at 62711-6444. Poola is affiliated with the IRCCO (ACO ID: A2619) and HSHS ACO, L.L.C. (ACO ID: A2783), participating under the MSSP model.

Poola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 345 traditional Medicare patients, billed 16,298 HCPCS/CPT codes, and received $231,588 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,801 prescription claims across 561 beneficiaries totaling $3,078,020 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 876 claims. Open Payments data shows 75 records totaling $1,448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $38,695 to $231,588. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $455,503 to $3,078,020. For DME billing, reported payments moved sharply higher in recent years, from $547 to $254,123.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	272	2,280	$38,695
2016	277	3,013	$42,546
2017	163	897	$26,829
2018	210	1,230	$44,213
2019	238	1,656	$59,050
2020	286	1,933	$66,235
2021	297	4,613	$112,797
2022	328	16,220	$197,062
2023	340	12,532	$184,169
2024	345	16,298	$231,588

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	183	1,648	$455,503
2016	210	2,142	$695,301
2017	255	1,346	$457,503
2018	186	2,354	$814,522
2019	234	2,927	$1,071,866
2020	351	3,584	$1,395,510
2021	380	3,941	$1,694,165
2022	436	4,555	$2,209,189
2023	527	5,512	$3,195,083
2024	561	6,801	$3,078,020

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	68	180	$3,487
2016	99	292	$9,653
2017	81	144	$2,574
2018	109	278	$20,916
2019	145	568	$72,807
2020	152	643	$90,830
2021	222	713	$93,753
2022	232	1,116	$194,083
2023	256	1,295	$222,774
2024	236	876	$265,921

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	289	650	$89
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	132	336	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	209	297	$13
83036	Hemoglobin a1c level	192	316	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	71	96	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	539	16,902	$616,149
Trulicity	Dulaglutide	510	16,647	$563,121
Jardiance	Empagliflozin	432	24,213	$463,889
Ozempic	Semaglutide	269	9,461	$280,485
Humulin R U-500 Kwikpen	Insulin Regular, Human	97	3,056	$152,589

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	110	457	$210,389
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	33	$17,679
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	51	$11,955
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	35	$8,513
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	29	29	$6,304

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,448	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rama Poola, MD?

Tedicare shows public-source Medicare data for Rama Poola, MD (NPI 1932362241), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rama Poola, MD have ACO affiliation data?

Rama Poola, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and HSHS ACO, L.L.C. (MSSP, ACO ID A2783).

What billing organization is linked to Rama Poola, MD?

Rama Poola, MD is linked to HSHS MEDICAL GROUP INC (billing NPI 1962644807) in the available physician profile data.

Does Rama Poola, MD have Open Payments data?

Rama Poola, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.